40 Participants Needed

IO vs IV Vancomycin for Preventing Infection in Shoulder Surgery

KI
HG
Overseen ByHaley Goble, MHA
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: The Methodist Hospital Research Institute
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to compare two different antibiotic regimens and techniques during total shoulder arthroplasty.Primary Objective: Comparable levels of vancomycin will be found in bone, soft tissue, and systemic samples between patient groups.Secondary Objective: Compare 30 day and 90 day post-operative complication rates (infection) between the control (standard IV administration of vancomycin) vs the interventional group (intraosseous administration of vancomycin). The investigators hypothesize that there will be no difference in complication (infection) rates between groups.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are taking medications that affect your immune system, you may not be eligible to participate.

Is vancomycin safe for use in surgeries?

Vancomycin is generally safe for use in surgeries, but it requires careful administration to avoid side effects. For example, intravenous vancomycin needs to be given slowly to prevent complications, and intraosseous vancomycin has been used safely in knee surgeries.12345

How does the drug vancomycin differ in preventing infections in shoulder surgery?

The use of intraosseous (IO) vancomycin in shoulder surgery is unique because it can provide higher local tissue concentrations compared to the traditional intravenous (IV) method, potentially leading to better infection prevention.12346

What data supports the effectiveness of the drug vancomycin in preventing infection in shoulder surgery?

Research suggests that vancomycin, when used as a preventive measure in surgeries like shoulder arthroplasty, can help reduce infections, especially when there is a risk of resistant bacteria. Intraosseous (IO) administration of vancomycin has shown to provide better local antibiotic concentration compared to intravenous (IV) methods in similar surgeries, like total knee arthroplasty, which may imply potential benefits for shoulder surgeries as well.12378

Are You a Good Fit for This Trial?

This trial is for adults over 18 who are having shoulder replacement surgery and can consent to the study. It's not for those with past shoulder surgeries, allergies to certain antibiotics like vancomycin, or conditions that make IO infusion impossible. People with diabetes, weakened immune systems, or a BMI above 35 are also excluded.

Inclusion Criteria

I am having shoulder replacement surgery.
Patient is able to give informed consent to participate in the study. LAR consents will not be utilized for this study
I am older than 18 years.

Exclusion Criteria

I have a weakened immune system due to a condition or treatment.
I have had shoulder surgery before.
My BMI is over 35.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-operative

Participants receive pre-operative antibiotic regimen including IV antibiotics approximately 1 hour prior to incision

1 day
1 visit (in-person)

Intra-operative

Participants undergo total shoulder arthroplasty with either IV or IO vancomycin administration; intra-operative sample collection occurs

1 day
1 visit (in-person)

Post-operative Monitoring

Participants are monitored for adverse reactions and vancomycin levels are measured

24 hours

Follow-up

Participants are monitored for post-operative complications and infection rates at 30 and 90 days

90 days

What Are the Treatments Tested in This Trial?

Interventions

  • Vancomycin
Trial Overview The study compares two ways of giving the antibiotic vancomycin during shoulder surgery: through IV (control) and directly into the bone (IO). The goal is to see if both methods deliver similar drug levels in tissues and have comparable infection rates after surgery at 30 and 90 days.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention - Intraosseous (IO) administration of vancomycinExperimental Treatment1 Intervention
Group II: Control - Standard IV administration of vancomycinPlacebo Group1 Intervention

Vancomycin is already approved in United States, European Union, Canada, Japan for the following indications:

🇺🇸
Approved in United States as Vancocin for:
🇪🇺
Approved in European Union as Vancomycin for:
🇨🇦
Approved in Canada as Vancomycin for:
🇯🇵
Approved in Japan as Vancomycin for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Methodist Hospital Research Institute

Lead Sponsor

Trials
299
Recruited
82,500+

Citations

When intravenous vancomycin prophylaxis is needed in shoulder arthroplasty, incomplete administration is associated with increased infectious complications. [2023]
Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty. [2022]
Vancomycin is effective in preventing Cutibacterium acnes growth in a mimetic shoulder arthroplasty. [2021]
Oral and IV Antibiotic Administration After Single-Stage Revision Shoulder Arthroplasty: Study of Survivorship and Patient-Reported Outcomes in Patients without Clear Preoperative or Intraoperative Infection. [2022]
Intraoperative Intra-articular Antibiotic Injection Reduces Infection in Shoulder Arthroplasty. [2023]
The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. [2019]
An intraoperative irrigation regimen to reduce the surgical site infection rate following adolescent idiopathic scoliosis surgery. [2022]
Otto Aufranc Award: Intraosseous Vancomycin in Total Hip Arthroplasty - Superior Tissue Concentrations and Improved Efficiency. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security